| |
 |
| |
AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER 2008
(Rs. In Lacs) |
| Particulars |
Quarter ended |
Quarter ended |
Half Year Ended |
Half Year Ended |
Year ended |
| 31st Dec 2008 |
31st Dec 2007 |
31st Dec 2008 |
31st Dec 2007 |
31st Mar 2008 |
1.
|
(a) |
(Net) Sales / Income from operations |
9,161 |
6,659 |
27,465 |
20,478 |
31,073 |
| |
(b) |
Other Operating Income |
|
|
|
|
|
| 2. |
Expenditure |
|
|
|
|
|
| |
(a) |
(Increase) / Decrease in stock in trade & WIP. |
670 |
(1,000) |
(517) |
(1,929) |
(924) |
| |
(b) |
Consumption of raw materials. |
5,286 |
4,989 |
16,921 |
13,893 |
18,259 |
| |
(c) |
Purchase of Traded Goods |
612 |
357 |
2,132 |
1,570 |
3,892 |
| |
(d) |
Employees cost |
255 |
236 |
778 |
704 |
980 |
| |
(e) |
Depreciation |
266 |
235 |
785 |
711 |
963 |
| |
(f) |
Other expenditure |
1,336 |
1,178 |
4,113 |
3,524 |
5,119 |
| |
(g) |
Total Expenditure |
8,425 |
5,995 |
24,212 |
18,492 |
28,289 |
| 3. |
Profit from Operations before Other Income, Interest & Exceptional Item |
736 |
665 |
3,253 |
1,986 |
2,783 |
| 4. |
Other Income |
10 |
22 |
16 |
88 |
184 |
| 5. |
Profit before Interest & Exceptional Items |
746 |
687 |
3,269 |
2,074 |
2,967 |
| 6. |
Interest |
600 |
232 |
1,764 |
597 |
1,184 |
| 7. |
Profit after Interest but before Exceptional Items |
146 |
455 |
1,505 |
1,477 |
1,783 |
| 8. |
Exceptional Items |
- |
- |
- |
- |
- |
| 9. |
Profit from Ordinary Activities before Tax |
146 |
455 |
1,505 |
1,477 |
1,184 |
| 10. |
Tax Expenses (Includes) |
91 |
127 |
457 |
352 |
476 |
| |
(a) |
Provision for Taxation |
35 |
55 |
268 |
175 |
230 |
| |
(b) |
Provision for FBT |
4 |
7 |
11 |
12 |
16 |
| |
(c) |
Provision for Deffered Taxation |
53 |
65 |
178 |
165 |
230 |
| 11. |
Net profit from ordinary Activities after Tax |
55 |
328 |
1,049 |
1,126 |
1,307 |
| 12. |
Extraordinay Item (net of tax expenses ) |
- |
- |
- |
- |
- |
| 13. |
Net Profit for the period |
55 |
328 |
1,049 |
1,126 |
1,307 |
| 14. |
Paid-up Equity Share Capital of Rs.10/- each. |
1,171 |
1,171 |
1,171 |
1,171 |
1,171 |
| 15. |
Reserves & Surplus (excluding revaluation reserves) |
- |
- |
- |
- |
- |
| 16. |
Basic & Diluted E P S(in Rs.) |
0.47 |
2.80 |
8.96 |
9.61 |
11.17 |
| 17. |
Public shareholding |
|
|
|
|
|
| |
-Number of Shares |
5627201 |
6113030 |
5627201 |
6113030 |
6045866 |
| |
-Percentage of Total Shareholding |
48.06 |
52.21 |
48.06 |
52.21 |
51.64 |
|
| |
| Notes : |
| 1. |
There were no pending complaints at the beginning of the Quarter. During the quarter three complaintswere received and redressed. There were no complaints pending at the end of the quarter. |
| 2. |
Company is operating as a Single Segment Company, engaged in pharmaceuticals business hence, the disclosure requirement as per AS - 17 'Segment Reporting' is not attracted. |
| 3. |
The figures of the previous periods have been regrouped and rearranged wherever necessary. |
| 4. |
The above results,have been reviewed by the Audit Committee, & approved by the Board of Directors at their meeting held on 29th January,2009. |
| For and on behalf of the Board |
| FOR AARTI DRUGS LIMITED |
| Place : Mumbai |
Harshit M Savla |
| Date : 29th January, 2009 |
(Jt. Managing Director) |
|
| |
| |
|
|
| |
| |
 |
| |
|
|
